Moreover, gene set enrichment analysis (GSEA) of gene expression profiling data from MM patient samples showed that increased EIF4E3 expression was predictive of Nrf2 activation in some chemoresistant minimal residual disease and relapsed/refractory MM cases. This evidence concerns the gene EIF4E3 and Miyoshi myopathy.